BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31612164)

  • 1. Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy.
    Wu M; Ding Y; Li L
    Nanoscale; 2019 Nov; 11(42):19658-19683. PubMed ID: 31612164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy.
    Gao Y; Tong H; Li J; Li J; Huang D; Shi J; Xia B
    Front Bioeng Biotechnol; 2021; 9():720508. PubMed ID: 34490227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-in-One Theranostic Nanoagent with Enhanced Reactive Oxygen Species Generation and Modulating Tumor Microenvironment Ability for Effective Tumor Eradication.
    Liu Y; Zhen W; Jin L; Zhang S; Sun G; Zhang T; Xu X; Song S; Wang Y; Liu J; Zhang H
    ACS Nano; 2018 May; 12(5):4886-4893. PubMed ID: 29727164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.
    Li Y; Yang J; Sun X
    Front Chem; 2021; 9():650587. PubMed ID: 33968899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-generating nanoplatforms as selective and tunable therapeutic weapons against cancer.
    Foglietta F; Serpe L; Canaparo R
    Discov Nano; 2023 Dec; 18(1):151. PubMed ID: 38078991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Specific Endogenous Fe
    Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy.
    Zhong Y; Li X; Chen J; Wang X; Wei L; Fang L; Kumar A; Zhuang S; Liu J
    Dalton Trans; 2020 Aug; 49(32):11045-11058. PubMed ID: 32756684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Combination of Copper Chalcogenide-Based Photothermal and Reactive Oxygen Species-Related Therapies.
    Zhao Y; Chen BQ; Kankala RK; Wang SB; Chen AZ
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4799-4815. PubMed ID: 33455213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titanium-Based Nanoarchitectures for Sonodynamic Therapy-Involved Multimodal Treatments.
    Maleki A; Seyedhamzeh M; Yuan M; Agarwal T; Sharifi I; Mohammadi A; Kelicen-Uğur P; Hamidi M; Malaki M; Al Kheraif AA; Cheng Z; Lin J
    Small; 2023 Mar; 19(12):e2206253. PubMed ID: 36642806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoplatform-based cascade engineering for cancer therapy.
    Chen J; Zhu Y; Wu C; Shi J
    Chem Soc Rev; 2020 Dec; 49(24):9057-9094. PubMed ID: 33112326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-mediated Therapeutics Combined with Metal-based Porphyrin Nanoparticles and their Applications in Tumor Treatment.
    Yang L; Shi L; Liu Y; Liu Z; Tian Z; Li H; Zhang J; He J; Liu Y
    Curr Med Chem; 2023 Oct; ():. PubMed ID: 37859412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese-Based Nanoplatform As Metal Ion-Enhanced ROS Generator for Combined Chemodynamic/Photodynamic Therapy.
    Wang P; Liang C; Zhu J; Yang N; Jiao A; Wang W; Song X; Dong X
    ACS Appl Mater Interfaces; 2019 Nov; 11(44):41140-41147. PubMed ID: 31603650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-Targeted and Ultrasound-Activated Nanodroplets for Enhanced Deep-Penetration Sonodynamic Cancer Therapy.
    Zhang L; Yi H; Song J; Huang J; Yang K; Tan B; Wang D; Yang N; Wang Z; Li X
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):9355-9366. PubMed ID: 30734551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
    Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
    J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.
    Wu D; Chen X; Zhou S; Li B
    Front Immunol; 2023; 14():1241791. PubMed ID: 37731484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics.
    Pan X; Wang H; Wang S; Sun X; Wang L; Wang W; Shen H; Liu H
    Sci China Life Sci; 2018 Apr; 61(4):415-426. PubMed ID: 29666990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An all-in-one theranostic nanoplatform based on upconversion dendritic mesoporous silica nanocomposites for synergistic chemodynamic/photodynamic/gas therapy.
    Liu S; Li W; Dong S; Zhang F; Dong Y; Tian B; He F; Gai S; Yang P
    Nanoscale; 2020 Dec; 12(47):24146-24161. PubMed ID: 33242048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species mediated theranostics using a Fenton reaction activable lipo-polymersome.
    You C; Gao Z; Wu H; Sun K; Ning L; Lin F; Sun B; Wang F
    J Mater Chem B; 2019 Jan; 7(2):314-323. PubMed ID: 32254556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Polyoxometalate Based Nanoplatforms Mediated Reactive Oxygen Species Cancer Therapy.
    Yue Z; Wang R; Li J; Tang M; Yang L; Gu H; Wang X; Sun T
    Chem Asian J; 2023 Nov; 18(22):e202300749. PubMed ID: 37755123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.